Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Xylo Technologies Ltd.

MDGSNASDAQ
Healthcare
Medical - Devices
$2.36
$0.22(10.28%)
U.S. Market is Open • 13:58

Xylo Technologies Ltd. Fundamental Analysis

Xylo Technologies Ltd. (MDGS) shows weak financial fundamentals with a PE ratio of -0.01, profit margin of -17.47%, and ROE of -51.10%. The company generates $164.9B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position12601.29%
PEG Ratio-0.00

Areas of Concern

ROE-51.10%
Operating Margin-25.43%
We analyze MDGS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -409.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-409.3/100

We analyze MDGS's fundamental strength across five key dimensions:

Efficiency Score

Weak

MDGS struggles to generate sufficient returns from assets.

ROA > 10%
-25.08%

Valuation Score

Excellent

MDGS trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

MDGS faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MDGS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.42
Current Ratio > 1
1.08

Profitability Score

Weak

MDGS struggles to sustain strong margins.

ROE > 15%
-5110.26%
Net Margin ≥ 15%
-17.47%
Positive Free Cash Flow
No

Key Financial Metrics

Is MDGS Expensive or Cheap?

P/E Ratio

MDGS trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, MDGS's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Xylo Technologies Ltd. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -6.54 times EBITDA. This is generally considered low.

-6.54

How Well Does MDGS Make Money?

Net Profit Margin

For every $100 in sales, Xylo Technologies Ltd. keeps $-17.47 as profit after all expenses.

-17.47%

Operating Margin

Core operations generate -25.43 in profit for every $100 in revenue, before interest and taxes.

-25.43%

ROE

Management delivers $-51.10 in profit for every $100 of shareholder equity.

-51.10%

ROA

Xylo Technologies Ltd. generates $-25.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-25.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Xylo Technologies Ltd. generates limited operating cash flow of $-11.23B, signaling weaker underlying cash strength.

$-11.23B

Free Cash Flow

Xylo Technologies Ltd. generates weak or negative free cash flow of $-14.37B, restricting financial flexibility.

$-14.37B

FCF Per Share

Each share generates $-189.64 in free cash annually.

$-189.64

FCF Yield

MDGS converts -4.47% of its market value into free cash.

-4.47%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.004

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.95

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.42

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.51

vs 25 benchmark

ROA

Return on assets percentage

-0.25

vs 25 benchmark

ROCE

Return on capital employed

-0.67

vs 25 benchmark

How MDGS Stacks Against Its Sector Peers

MetricMDGS ValueSector AveragePerformance
P/E Ratio-0.0129.43 Better (Cheaper)
ROE-51.10%800.00% Weak
Net Margin-17.47%-20145.00% (disorted) Weak
Debt/Equity0.420.30 Weak (High Leverage)
Current Ratio1.084.64 Neutral
ROA-25.08%-17936.00% (disorted) Weak

MDGS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Xylo Technologies Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ